Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06162832
PHASE2

Periodontal Regeneration With Recombinant Human Platelet Derived Growth Factor (rH-PDGF-BB) and Allograft

Sponsor: Universidad Autonoma de Nuevo Leon

View on ClinicalTrials.gov

Summary

Growth factors are defined as small proteins that trigger a cellular response after binding to cell receptors; Tissue engineering is now clinically applicable in a commercially available system involving the use of recombinant human platelet-derived growth factor. The objective of this study is to evaluate clinical and radiographic parameters in bone defects treated with platelet-derived growth factor in combination with allograft. Our hypothesis: Defects treated with DFDBA and rhPDGF-BB have better clinically and radiographic results that the defects treated with DFDBA and saline solution.

Official title: Evaluation of Clinical and Radiographic Parameters in Bony Defects Treated With Recombinant Human Platelet-derived Growth Factor in Combination With Allograft

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2024-01-10

Completion Date

2025-01-15

Last Updated

2024-05-01

Healthy Volunteers

Yes

Interventions

COMBINATION_PRODUCT

Allograft and rHPDGF-BB

At this intervention the periodontal defect will be treated with allograft and rHPDGF-BB (GEM21)

COMBINATION_PRODUCT

Allograft and Saline solution

This will be used as the control group

Locations (1)

Posgrado de Periodoncia, Facultad de Odontología, Universidad Autónoma de Nuevo León

Monterrey, Nuevo León, Mexico